AstraZeneca ha presentato la sua strategia per la competitività e la crescita in Italia, mettendo in evidenza la ricerca clinica e l'innovazione come leve cruciali e promuovendo un modello di cooperazione tra pubblico e privato per attrarre investimenti nel settore delle Life Science. #RicercaClinica #Innovazione #LifeSciences
Blending together dozens of ingredients, researchers at the University of Minnesota have synthesized simple cells that feed, grow, reproduce, compete with one another for food. If these cells are not yet fully alive, they have most of the hallmarks of life https://t.co/XS2I8mzpTg #SyntheticBiology #LifeSciences #MinnesotaResearch #Therearenospecificcountrycodespresentinthetweet.
We discussed priorities for the EU Trade Council, including progress on free trade agreements, the EU–US trade relationship, and advancing the Life Sciences Strategic Task Force that Ireland has called for. https://t.co/aCS1zS0HSH #EUTradeCouncil #FreeTrade #LifeSciences #EU #US #IE
We discussed priorities for the EU Trade Council, including progress on free trade agreements, the EU–US trade relationship, & advancing the Life Sciences Strategic Task Force that Ireland has called for. #EUTradeCouncil #FreeTrade #LifeSciences #EU #US #IE
Spitzenmedizin sichert die Lebensqualität und verbessert die Gesundheit: Bayern investiert massiv in Medizin mit Hightech und Herz. Wir wollen der Life-Science-Standort Nummer 1 in Deutschland und ganz Europa werden. Innovation und Forschung haben für uns Priorität. Heute war https://t.co/gUPHjSLA1h #Spitzenmedizin #Innovation #LifeSciences #DE #EU
Biotech can change the future of medicine. Good meeting this week with @karlnehammer, @EIB Group VP for Life Sciences & TechEU, on #BioTechEU: €10bn for biotech to help innovation grow in Europe and reach patients faster. Learn more here: https://t.co/BZBGM8D8LZ https://t.co/d7aAZ4kB1u #Biotech #Innovation #LifeSciences #EU #AT
AstraZeneca has announced a £300 million investment in UK drug development, reversing a previous decision to pause investment in Cambridge, which is expected to boost local employment and enhance patient access to clinical trials, amid changes in pharmaceutical pricing agreements between the UK and US. #PharmaceuticalIndustry #Investment #LifeSciences #UK #US
